Cervical cancer Flashcards

1
Q

Cervical cancer, percentage of total female cancers

A

13% of gyn cancers

4% when including breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for cervical disease

A
  1. Sexual activity (includes HPV infection)
  2. Immune deficiency (HIV, steroids, smoking)
  3. Poor screening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Usual presentation of early cervical cancer

A

Abnormal screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Progression of squamocolumnar junction over time

A

Recedes into endocervix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Endocervix cell types

A

Columnar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ectocervix cell types

A

Squamous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alternative HPV testing guideline for paps

A

HPV alone every 5 years starting at 25 y/o

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When to discontinue pap screening

A

65 y/o IF no hx of CIN2-3 in last 20 years, no hx of cervix cancer, no DES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Koilocytosis is pathognomonic for ___

A

LSIL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Proportion of cervical cancer caused by HPV 16/18

A

70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Low-risk HPV associated with condyloma and CIN1

A

HPV 6/11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Duration of HPV infection

A

Median 8 mos
70% resolve by 12 mos
>90% resolve by 24 mos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Progression of HPV to invasive cancer takes how long?

A

10-20 yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Advantage to HPV primary screening

A

Sensitive (good NPV), improve detection of glandular cell abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Disadvantage to HPV primary screening

A

Low specificity (low PPV), increased referrals for colpo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Trial that made HPV primary testing more acceptable

A

ATHENA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Acetowhite epithelium is ___

A

Intracellular keratin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How Lugol’s works

A

Stains glycogen brown in normal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What Lugol’s shows better

A

Vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Dysplasia development histologically

A

Starts at the basement membrane and makes its way to the epithelial surface (CIN1 is one layer at membrane and CIN is almost to surface (CIS includes epithelium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Indications for ECC

A

Inadequate colpo, concern for endocervical extension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cure rate of conization (LEEP, CKC, laser cone)

A

95%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When not to do laser ablation or cryotherapy

A

If colpo unsatisfactory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When to do conization

A

CIN 2-3 or high-grade screen with low-grade histology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Outcomes from positive margins following excision

A

67% resolve spontaneously

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Management for positive margins following excision

A

Pap + ECC in 6 mos (then repeat excision if CIN 2-3) OR just repeat excision in 6 wks (preferred only for AIS)

27
Q

What if CIN1 persists beyond 2 yrs?

A

Continue follow-up vs excision

28
Q

At what age does endometrial cells on pap matter?

A

40 y/o

29
Q

What to do if premenopausal with endometrial cells on pap?

A

Asymptomatic > routine follow-up

Symptomatic > endometrial sampling

30
Q

What to do if postmenopausal with endometrial cells on pap?

A

Endometrial sampling regardless of symptoms

31
Q

What to do for AGC

A

HPV test, colpo, and ECC; add endometrial sampling if >35 y/o or risk factors

32
Q

What to do for atypical endometrial cells

A

HPV test, colpo, ECC, endometrial sampling

33
Q

What to do if AGC or AIS and no e/o invasive disease

A

Excisional procedure

34
Q

What to do if AIS on excisional procedure

A

Hysterectomy vs cautious observation if fertility desired

35
Q

LEEP during pregnancy?

A

Acceptable for CIN3 vs waiting till 6 wks postpartum

36
Q

When to start screening for HIV pos

A

Within one year of starting sexual activity

37
Q

When to stop screening for HIV pos

A

Never

38
Q

What is more common in HIV with CD4<500?

A

Glandular cell abnormalities

39
Q

Conization should be done before hysterectomy in setting of CIN IF…

A

Unsatisfactory colpo
Suspicion for cancer
ECC w/ CIN2-3
Evidence of high-grade glandular neoplasia

40
Q

Proportions of squamous vs adenocarcinoma of cervix

A

Squamous 70%

Adeno 20-25%

41
Q

Tools for FIGO staging of cervical cancer

A

EUA, cystoscopy, proctoscopy, IVP, CXR (or may substitute CT or PET)

42
Q

Mnemonic for cervical cancer staging

A

Down and out

43
Q

FIGO stage I-IV locations

A

I - cervix
II - uterus / upper vagina
III - lower vagina / pelvic sidewall
IV - outside of pelvis

44
Q

Survival rates by staging

A

I - 90%
II - 70%
III - 40%
IV - 15%

45
Q

Stage I divisions

A
IA1 - <3 mm
IA2 <5 mm
IB1 >5 mm and <2 cm wide
IB2 >5 mm and 2-4 cm wide
IB3 >5 mm and > 4 cm wide
46
Q

Stage II divisions

A

IIA1 - upper 2/3 vagina, <4 cm
IIA2 - upper 2/3 vagina, >4 cm
IIB - parametrial involvement

47
Q

Stage III divisions

A

IIIA - lower 1/3 of vagina
IIIB - pelvic sidewall
IIIC1 - pelvic LN
IIIC2 - paraortic LN

48
Q

Stage IV divisions

A

IVA - adjacent organs

IVB - distant spread

49
Q

Treatment for IA1

A

Hysterectomy

50
Q

Treatment for IA2

A

Modified radical hysterectomy + PLND

51
Q

Treatment for IB1

A

Rad hysterectomy + PLND

52
Q

Treatment for IB2 and above

A

Chemo-RT + brachytherapy

53
Q

Most common early complications of radical hysterectomy

A

UTI, ileus, fever, DVT

54
Q

Most common late complications of radical hysterectomy

A

Urinary retention, lymphedema, sexual dysfunction

55
Q

When to use radiation as adjuvant therapy

A

Positive LN at time of surgery, risk factors like large tumor, deep invasion, parametrial extension, positive margins

56
Q

How chemoradiation works

A

Low-dose chemo sensitizes cells to radiation

57
Q

Management of acute bleeding in cervical cancer

A

Vaginal packing with Monsel’s
Embolization
“Hot shot” or traditional brachytherapy

58
Q

How to treat cervical cancer at 24 wga or above

A

Consider neoadjuvant chemotherapy

Deliver by Classical C/S

59
Q

How to treat cervical cancer <24 wks and no desire to continue pregnancy

A

Stage I-IIA: rad hyst + LND

Stage IIB - IVA: pelvic chemo-RT, SAB vs D&E, brachytherapy

60
Q

Surveillance post-treatment for cervical cancer

A

Every 3 months x 2 yrs
Every 6 mo to 5 yrs
Annually after that

61
Q

What to do for vaginal bleeding after radiation treatment for cervical cancer

A

Colpo, pack with Monsel’s, embolization, hysterectomy (last resort because risk for complications)

62
Q

Treatment for central recurrence

A
Radiation (if s/p rad hyst)
Pelvic exenteration (if s/p radiation)
63
Q

Treatment for lateralized pelvic recurrence

A

Chemo-RT (if s/p rad hyst)

Chemo (if s/p radiation)

64
Q

Treatment for distant recurrence

A

Systemic chemo